Discover 833 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 833
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Quebec, Sherbrooke, White Plains NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase3, Recruiting
Alberta Chiropractic SelfBack Study
for
Chronic Low-back Pain
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18+
Code: NCT06347991
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
for
H3 K27M, Glioma
Location: Montreal, Ottawa, Toronto, London, Calgary, Vancouver
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 0+
Code: NCT05580562
Phase3, Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Location: Bridgewater, New Haven CT, Quebec, Bristol CT,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06632444
Phase3, Recruiting
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
for
Arrhythmogenic Cardiomyopathy,
Location: St. John's, Halifax, Quebec, Montreal,
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 18+
Code: NCT06174220
Phase2, Recruiting
Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
for
Cancer, Prostate Cancers, Breast Cancers, Colon Cancer,
Location: Halifax, Montreal, Toronto, Calgary, Vancouver
Sponsor: University of Calgary
Sex: All
Age: 18+
Code: NCT06960291
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: St. John's, Sydney, Halifax, Moncton, Saint John,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT04792489
Phase2, Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for
Urothelial Carcinoma
Location: Worcester MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04879329
Phase2, Recruiting
Optimizing Recruitment to Drive Equitable Research Opportunity in Stroke Rehabilitation Trials in Canada
for
Stroke
Location: Halifax, London, Calgary, Vancouver
Sponsor: McMaster University
Sex: All
Age: 18+
Code: NCT06576089
Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Halifax, Boston MA, Quebec, Egg Harbor NJ, Montreal,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase3, Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: St. John's, Halifax, Boston MA, Quebec, Woodbury NY,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase3, Recruiting
Cardiovascular Imaging Registry of Canada
for
Cardiovascular Diseases
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18+
Code: NCT04367220
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Sydney, Boston MA, Quebec, Massapequa NY, The Bronx NY,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase3, Recruiting
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
for
Atrial Fibrillation, Stroke, Bleeding
Location: Portland ME, Boston MA, New Haven CT, Lebanon NH,
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT04045665
Phase3, Recruiting
An Efficacy Study of Exercise Rehabilitation on Pain and Disability for Patients With Non-specific Low Back Pain
for
Low Back Pain, Mechanical
Location: Calgary
Sponsor: Running Injury Clinic
Sex: All
Age: 18 - 65
Code: NCT01567566
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, Quebec, New Brunswick NJ, Montreal,